NSEGeneral Updates3 Jul 2026 · 3 Jul 2026, 12:42 pm

General Updates

Marksans Pharma Limited · MARKSANS

✦ AI SummaryResults

Marksans Pharma Limited has informed the Exchange about General Updates regarding Annual General Meeting scheduled to be held on 27 August 2026. The company has fixed Thursday, 20 August 2026 as the Record Date for determining eligibility of Members to receive final dividend for the financial year ended 31 March 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Limited has informed the Exchange about General Updates regarding Annual General Meeting scheduled to be held on 27 August 2026.

Attachments (1)

📄

MARKSANS_03072026124233_SEIntimation.pdf

pdf

Download →
View document text
Date: July 03, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS Sub: Outcome of Board Meeting Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and other regulations, if applicable, please be informed that, the Board of Directors (“Board”) of the Company at its meeting held today i.e. July 03, 2026 has, inter alia, considered and approved the following: 1. The 34th Annual General Meeting (“AGM”) of the Members of the Company will be held on Thursday, 27 August 2026 at 11:00 a.m. (IST) through Video Conferencing (VC)/Other Audio Visual Means (OAVM). The Notice of AGM along with the Annual Report for FY 2026 will be sent through electronic mode to those Members whose email addresses are registered with the Company/ Registrar and Transfer Agent of the Company/ Depositories in due course, within the prescribed timelines. The Notice of the AGM and the Annual Report will also be available on the website of the Company and website of the Stock Exchanges, in due course. 2. The Company has fixed Thursday, 20 August 2026 as the Record Date for determining eligibility of Members to receive final dividend for the financial year ended 31 March 2026. The Board, at its meeting held on 26 May 2026, has recommended a final dividend of ₹ 0.90/- (90%) per equity share of face value of ₹ 1/- each for the financial year ended 31 March 2026, subject to approval of Members of the Company at the ensuing AGM. The final dividend, if approved at the AGM, will be paid, subject to deduction of tax at source, on or after Thursday, 10 September 2026. The meeting commenced at 11:15 a.m. and concluded at 11:50 a.m. We request you to note the aforesaid in your records. Thanking You, Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary